Alevin Therapeutics Limited
13971892
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/03/2025
micro entity
Next accounts due
31/12/2026
Confirmation statement
Last: 10/03/2026
Due 24/03/2027
Industry
Officers
director · Since 20/04/2022
LIFE SCIENCES EXECUTIVE
BRITISH · UNITED KINGDOM · Age 49
Also on 1 other board
director · Since 20/04/2022
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 53
Also on 11 other boards
Persons with Significant Control
O2h Nominees Limited (On Behalf Of O2h Ventures Limited)
Hauxton House Mill, Scitech Park, Mill Lane, Cambridge, CB22 5HX
Reg: 12251715 · Companies House · Limited
Notified 22/07/2022
University Of Nottingham
University, Park, Nottingham, NG7 2RD
Reg: Rc000664 · Uk · Exempt Charity
Notified 22/07/2022
Former PSCs
Mr Thomas Mcinally
Ceased 22/07/2022
Mr Simon John Fawcett Macdonald
Ceased 22/07/2022
CompanyRankvs 2053+ SIC 72190 peers64
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£366k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£354k
Working capital
Current Assets
£367k
Current Liabilities
£14k
Fixed Assets
£12k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 25.38 | -£108k |
| 2024 | 68.42 | -£233k |
| 2023 | 12.25 | — |
Derived from filed accounts. Not audited figures.